Dynamic temporal and spatial regulation of the cdk inhibitor p57kip2 during embryo morphogenesis
Research output: Contribution to journal › Article
Colleges, School and Institutes
The complete developmental expression pattern of the cyclin dependent kinase inhibitor (CDKI) p57(kip2) has not been reported, here we report a detailed study of the localization of p57(kip2) protein during mouse organogenesis. We show that p57(kip2) is coincident with key stages of differentiation of several organs, some but not all of which are affected in Beckwith-Weidermann syndrome, a human congenital syndrome characterized by foetal overgrowth and childhood tumours.
|Number of pages||7|
|Journal||Mechanisms of Development|
|Publication status||Published - 1 Nov 2001|
- genomic imprinting, organogenesis, localization, apoptosis, cyclin dependent kinase inhibitor, programmed cell death, insulin-like growth factor, Beckwith-Weidemann syndrome, embryonic, cell cycle, skeletal muscle, p57kip2, embryogenesis, cell cycle control, morphogenesis, placenta, omphalocele, kidney, protein distribution, mouse development, mosaicism, lung development